Table 1.
Structure of the experiment.
| Groups | n | Drug treatment | Agents administrated to induce inflammation | |
|---|---|---|---|---|
| Group I | Normal control | 10 | — | — |
| Group II | Chronic prostatitis | 10 | — | E2 0.25 mg/kg (s.c.) + DHT 0.25 mg/kg (s.c.) |
| Group III | Oligonol | 9 | Oligonol 60 mg/kg (p.o.) | 10 E2 0.25 mg/kg (s.c.) + DHT 0.25 mg/kg (s.c.) |
| Group IV | Acupuncture | 7 | — | 10 E2 0.25 mg/kg (s.c.) + DHT 0.25 mg/kg (s.c.) |
| Group V | Quantum | 7 | — | 10 E2 0.25 mg/kg (s.c.) + DHT 0.25 mg/kg (s.c.) |
| Group VI | Oligonol + quantum | 8 | Oligonol 60 mg/kg (p.o.) | 10 E2 0.25 mg/kg (s.c.) + DHT 0.25 mg/kg (s.c.) |
| Group VII | Acupuncture + oligonol | 9 | Oligonol 60 mg/kg (p.o.) | 10 E2 0.25 mg/kg (s.c.) + DHT 0.25 mg/kg (s.c.) |
| Group VIII | Quantum + acupuncture | 8 | — | 10 E2 0.25 mg/kg (s.c.) + DHT 0.25 mg/kg (s.c.) |
| Group IX | Quantum + oligonol + acupuncture | 9 | Oligonol 60 mg/kg (p.o.) | 10 E2 0.25 mg/kg (s.c.) + DHT 0.25 mg/kg (s.c.) |
E2, 17-beta-estradiol; DHT, dihydrotestosterone; s.c., subcutaneous injection; p.o., oral administration.